Network Immunology Inc. is a privately held biotechnology company developing novel immuno-therapies based on immune network theory.
Toronto, ON: Network Immunology has received breakthrough data for its platform Co-selection Technology™ that has potential applications to transplantation, autoimmunity and other degenerati..
Vancouver, BC: Network Immunology has completed a financing in partnership with one of the largest wealth management firms in Canada. “We are delighted with this development, as it is a majo..
Atlanta, GA: Network Immunology reports highly encouraging results have been observed with respect to its HIV therapeutic technology, TheraNet™. In the company’s first study involving ..